Skip to content

Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain

CompletedPhase 3NCT00195728
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of the study is to evaluate the safety of Vicodin CR (combination opioid and acetaminophen containing product) in patients with chronic pain due to osteoarthritis or low back pain.

Study details

Official title
An Open-Label Study Evaluating the Safety and Tolerability of Long Term Administration of Hydrocodone/Acetaminophen Extended ReleaseTablets (Vicodin® CR) in Subjects With Moderate to Severe Chronic, Non-Malignant Pain
Conditions
  • Moderate to Severe Chronic, Non-malignant Pain
Interventions
  • Drug: Hydrocodone/Acetaminophen on Extended Release
Sponsor
Abbott
Start date
2005-06
Primary completion
2006-12
Sex
All
Age range
from 21 Years to 75 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
76

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Males and Females between 21 and 75 years of age * Females must be of non-child bearing potential or practicing birth control * Moderate to severe mechanical low back pain OR moderate to severe OA of the hip or knee pain * Require medicine for pain the majority of days in the previous 3 months, AND for at least 4 days per week, during the previous 4 weeks. * Pain is not controlled with non-opioid analgesics or is contraindicated due to side effects and/or currently receiving opioid therapy equivalent to 40 mg/day of morphine or less Exclusion Criteria: * Pregnant and/or breastfeeding females or females planning to become pregnant during the course of the study * Incapacitated, bedridden, or confined to a wheelchair permitting little or no self-care * Injury to the index joint or lower back within 3 months of study * History of any of the following: * Major surgery to the lower back within the last 5 years OR * Joint replacement/reconstruction to the index joint OR * Arthroscopic or open surgery to the index joint within the last year OR * Any surgery within 3 months of study * Osteoporotic compression fracture, traumatic vertebral fracture or invasive intervention for low back pain within the last year. * Abnormal neurological exam, or lower extremity symptoms characteristic of neurogenic pain * History of inflammatory or infectious arthritis, tumors or infections of spinal cord, spinal stenosis, fibromyalgia or other chronic painful condition * Severe gastrointestinal narrowing * History of peritonitis, cystic fibrosis, chronic intestinal eudoobstruction, or Meckel's diverticulum. * Has received * Oral, intramuscular (IM), intravenous (IV) or non-index joint intra- articular corticosteroids within 1 month of study OR * Intra-articular corticosteroids at the index joint or epidural corticosteroids to the lower back region within 2 months of study, OR * Viscosupplementation therapy to index joint within 4 months of study * History of drug (licit or illicit) or alcohol abuse/addiction * Positive result for drugs of abuse at screening. * Chronic heavy drinker, consuming more than 4 alcoholic drinks per day. * History of malnutrition or starvation or is likely to fast for more than 4 consecutive days during the course of the study. * Medical condition or illness other than OA/CLBP, which is not well controlled * History of allergic reaction or a clinically significant sensitivity or intolerance to opioids and/or acetaminophen. * Newly dia…

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00195728